|
Oracle's complete industry solution footprint uniquely enables life sciences companies to innovate, manufacture, and sell more effectively—all while managing compliance and minimizing risk. Addressing key challenges such as costly, high-risk discovery periods and shrinking patent expiration limits, Oracle's solutions are a powerful combination of technology and comprehensive preintegrated business applications.
- 12 of the 12 pharmaceutical companies of Fortune Magazine's 2005 global top 500 run Oracle Applications
- 10 of the top 10 contract research organizations (CRO) run Oracle Applications
|